A diminished GABAergic input to the hypothalamic paraventricular nucleus may contribute to the activation of corticotropin releasing hormone-immunoreactivity neurons in depression, most prominently in major depression, which provides a rationale for prescribing GABAergic agonists for these patients (40). This evidence concerns the gene CRH and depressive disorder.